TB
Healthcare & Life Sciences
Tolerance Bio
United Statestolerancebio.com
Tolerance Bio is a Healthcare & Life Sciences startup based in the United States, most recent round Seed, 2 tracked investors.
Activeseed
seed
Stage
2023
Founded
2
Investors
About Tolerance Bio
Based in the United States, Tolerance Bio is a startup founded in 2023. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Tolerance Bio develops therapies that restore, preserve, and manipulate thymus function to improve immune tolerance and extend healthspan.
Explore Tolerance Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.